Cape Town - 2026 ISMRM-ISMRT Annual Meeting and Exhibition
9 May 2026 – 14 May 2026 · Cape Town, South Africa
451-03-012 / 451-03-012 MRI in Clinical Practice Abstract

MRI in Clinical Practice: HFpEF With Normal NT-proBNP—Multiparametric CMR Confirms Diffuse Myocardial Fibrosis

Accepted
Rui Zhang1, Yi Zhu2,3,4,5,6
1The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China
2Clinical and Technical Support, Philips Healthcare (Xi'an), Xi'an, China
3Department of Clinical & Technical Support, Clinical and Technical Support, Philips Healthcare (Xi'an), Xi'an, China
4Department of Clinical & Technical Support, Philips Healthcare (Beijing), Beijing, China
5Philips Healthcare (Beijing), Beijing, China
6Clinical and Technical Support, Philips Healthcare (Beijing), Beijing, China
Presenting Author: Jianxin Guo

Synopsis

Full abstract & presentation

The full text, figures, and any recorded presentation for this abstract are not shown here. Log in if you are a member or registered attendee with access.

Full abstracts, figures, and presentations for Cape Town - 2026 ISMRM-ISMRT Annual Meeting and Exhibition are available to registered attendees. This content becomes freely available to the public roughly two years after the meeting.

To request or purchase access, contact the ISMRM Central Office at info@ismrm.org.

Log in

References

1. Heidenreich PA, et al. 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure. Circulation. 2022.
2. Buckley LF, et al. Low NT-proBNP levels in overweight/obese patients do not rule out HFpEF. ESC Heart Fail. 2018.
3. Kozhuharov N, et al. Clinical effect of obesity on NT-proBNP. Eur J Heart Fail. 2022.
4. Haaf P, et al. Cardiac T1 mapping & ECV in diffuse myocardial fibrosis. J Cardiovasc Magn Reson. 2017.

Cite this abstract